ELAVL1 and prostate carcinoma: This negative impact on HuR expression induced docetaxel cytotoxicity in prostate cancer cells [190] by reducing the expression of ABCG2 (ATP Binding Cassette Subfamily G Member 2), a transporter involved in chemoresistance.